Brown, J. W. L., Martin, P. J., Thorpe, J. W., Michell, A. W., Coles, A. J., Cox, A. L., . . . Zandi, M. S. (2014). Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. Journal of neuroimmunology, 271(1-2), 66-68. https://doi.org/10.1016/j.jneuroim.2014.03.012
Chicago-Zitierstil (17. Ausg.)Brown, J. William L., Peter J. Martin, John W. Thorpe, Andrew W. Michell, Alasdair J. Coles, Amanda L. Cox, Angela Vincent, und Michael S. Zandi. "Long-term Remission with Rituximab in Refractory Leucine-rich Glioma Inactivated 1 Antibody Encephalitis." Journal of Neuroimmunology 271, no. 1-2 (2014): 66-68. https://doi.org/10.1016/j.jneuroim.2014.03.012.
MLA-Zitierstil (9. Ausg.)Brown, J. William L., et al. "Long-term Remission with Rituximab in Refractory Leucine-rich Glioma Inactivated 1 Antibody Encephalitis." Journal of Neuroimmunology, vol. 271, no. 1-2, 2014, pp. 66-68, https://doi.org/10.1016/j.jneuroim.2014.03.012.